Bone Biologics's total assets for Q3 2025 were $6.35M, a decrease of -9.30% from the previous quarter. BBLG total liabilities were $334.28K for the fiscal quarter, a -17.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.